156 related articles for article (PubMed ID: 38411836)
1. MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.
Mohan D; Nambirajan A; Malik R; Sharma A; Suri V; Kaur K; Doddamani R; Garg A; Gupta S; Mallick S; Sharma MC
Hum Cell; 2024 May; 37(3):704-713. PubMed ID: 38411836
[TBL] [Abstract][Full Text] [Related]
2. Ependymomas of the spinal region in adults: Clinical and pathological features and MYCN expression levels in spinal ependymomas and myxopapillary ependymomas.
Topel G; Dirilenoğlu F; Sevin İE; Kahraman A
Ann Diagn Pathol; 2024 Jun; 70():152299. PubMed ID: 38555652
[TBL] [Abstract][Full Text] [Related]
3. Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.
Swanson AA; Raghunathan A; Jenkins RB; Messing-Jünger M; Pietsch T; Clarke MJ; Kaufmann TJ; Giannini C
J Neuropathol Exp Neurol; 2019 Sep; 78(9):791-797. PubMed ID: 31373367
[TBL] [Abstract][Full Text] [Related]
4. Clinically aggressive pediatric spinal ependymoma with novel MYC amplification demonstrates molecular and histopathologic similarity to newly described MYCN-amplified spinal ependymomas.
Shatara M; Schieffer KM; Klawinski D; Thomas DL; Pierson CR; Sribnick EA; Jones J; Rodriguez DP; Deeg C; Hamelberg E; LaHaye S; Miller KE; Fitch J; Kelly B; Leraas K; Pfau R; White P; Magrini V; Wilson RK; Mardis ER; Abdelbaki MS; Finlay JL; Boué DR; Cottrell CE; Ghasemi DR; Pajtler KW; Osorio DS
Acta Neuropathol Commun; 2021 Dec; 9(1):192. PubMed ID: 34895332
[TBL] [Abstract][Full Text] [Related]
5. High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma.
Raffeld M; Abdullaev Z; Pack SD; Xi L; Nagaraj S; Briceno N; Vera E; Pittaluga S; Lopes Abath Neto O; Quezado M; Aldape K; Armstrong TS; Gilbert MR
Acta Neuropathol Commun; 2020 Jul; 8(1):101. PubMed ID: 32641156
[TBL] [Abstract][Full Text] [Related]
6. MYCN amplification drives an aggressive form of spinal ependymoma.
Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
[TBL] [Abstract][Full Text] [Related]
7. Implications of DNA Methylation Classification in Diagnosing Ependymoma.
Abe E; Suzuki M; Ichimura K; Arakawa A; Satomi K; Ogino I; Hara T; Iwamuro H; Ohara Y; Kondo A
World Neurosurg; 2024 May; 185():e1019-e1029. PubMed ID: 38479644
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic histology and distinct molecular features in a small series of spinal cord ependymomas.
Schüller U; Gocke A; Godbole S; Delbridge C; Thomas C; Neumann JE
Acta Neuropathol; 2024 May; 147(1):83. PubMed ID: 38735021
[No Abstract] [Full Text] [Related]
9. The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2.
J Neurosurg Spine; 2017 Apr; 26(4):474-482. PubMed ID: 27982762
[TBL] [Abstract][Full Text] [Related]
10. Pediatric spinal ependymoma with chromothripsis of chromosome 6: a case report and review of the literature.
Scott KR; Gener MA; Repnikova EA
J Med Case Rep; 2024 Feb; 18(1):95. PubMed ID: 38351155
[TBL] [Abstract][Full Text] [Related]
11. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
13. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
[TBL] [Abstract][Full Text] [Related]
14. MYCN amplification in spinal ependymoma: A five-year retrospective study.
Rao S; Sugur H; Konar S; Arivazhagan A; Santosh V
Neuropathology; 2023 Dec; 43(6):457-462. PubMed ID: 37221449
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
[TBL] [Abstract][Full Text] [Related]
16. Ependymal Tumors: Overview of the Recent World Health Organization Histopathologic and Genetic Updates with an Imaging Characteristic.
Soni N; Ora M; Bathla G; Desai A; Gupta V; Agarwal A
AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38844368
[TBL] [Abstract][Full Text] [Related]
17. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between
Santiago T; Tarek N; Boulos F; Hayes C; Jeha S; Raimondi S; Rodriguez-Galindo C
J Glob Oncol; 2019 Jul; 5():1-7. PubMed ID: 31365300
[TBL] [Abstract][Full Text] [Related]
19. Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.
Plotkin SR; O'Donnell CC; Curry WT; Bove CM; MacCollin M; Nunes FP
J Neurosurg Spine; 2011 Apr; 14(4):543-7. PubMed ID: 21294614
[TBL] [Abstract][Full Text] [Related]
20. MYCN protein stability is a better prognostic indicator in neuroblastoma.
Yang Y; Zhao J; Zhang Y; Feng T; Yv B; Wang J; Gao Y; Yin M; Tang J; Li Y
BMC Pediatr; 2022 Jul; 22(1):404. PubMed ID: 35820898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
